Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
New poster and current shareholder.
The potential inability to trade Accustem shares is the only thing putting me off holding beyond 29 Oct. Assuming that TILS will drop 50% on the 30th, I’m considering selling before and re-purchasing. This is probably short sighted, but I’m wary of tying up capital in an untradeable stock.
Is anyone else leaning the same way?
Good point. Very contradictory situation.
I wonder if this is just a disguise for enabling IIs to take a stake in DNL which would have been difficult to acquire in the open market? I would like to see director participation.
This placing is more than a 10% dilution so potential for some tr-1s in the coming weeks.
cteal, thanks for the perspective. You’re certainly right that it isn’t necessarily RG. I suppose I have been making assumptions based on recent holdings RNS flow. The stock is fairly sticky and there are a number of institutions who admittedly could also be selling, although the manner in which it’s being executed is questionable for them. Could be smaller holders, I suppose, but I do think that it’s RG, and the quoted spread is masking the true direction of the trades. Hopefully some news will tell because this drop is frustrating.
I just had to buy more. This is just silly. On a 2hr and 4hr chart the MACD looks like it’s approaching an inflection point which, coupled with my reasoning that RG probably doesn’t have many left (if indeed he’s closing his position entirely), gives me a little more confidence that we’re at, or very close to, the bottom.
Surely he could have tried to locate buyers for big chunks of his stock rather than hammering away at the sell button all day? Flooding the market carelessly with so much stock is just dragging the price down unfairly. Consider DNL just became only the third AIM company to get FDA approval and the price is just sliding. Ridiculous.
Who knows why he’s truly selling. Tax obligations seem reasonable, or simply it’s reallocation of capital into what he sees as better opportunities. He’s been buying heavily in TRX for one. At his level, and when you’re worth a few hundred mil, it’s a different game. Although he’s got a good track record, he’s not an oracle, and he even sold out of SNG before it rocketed this year. The market interest garnered from the FDA approval date has simply provided him with the liquidity he needed. There’s little reason that the fundamentals shouldn’t keep pushing the sp higher in the coming months.
Some expectation of approval priced in it seems, but overwhelming selling from RG is my prediction as to why the share price has barely moved. He’s been continuously selling into the market rather than offering shares to an II. Happy to see approval after yesterday’s pm wobble though and good prospects going forward.
Looks like panic selling, which is understandable I suppose. Very difficult to sit and watch the price decline, but there is no official news yet. I’m trying to take comfort that Alkindi has already been approved in the UK, Germany and Israel. Still, can’t find any official news yet so I don’t think there’s a leak.
RG almost certainly selling if his recent activity is anything to go by, but we’ll soon find out as he’ll have to disclose one last time before he hits 3%. I don’t read into it too much as he did the same with SNG before it mooned. Perhaps he’s not taking any risks just in case the expected FDA approvals don’t come to fruition.
... is there still no company comment re the share price movement?
It’s quite clear than a big holder is dumping hard, and it’s likely Helios with the diarrhoea-like sales. This thing has prolapsed. Director buys are about the only thing that’ll resuscitate this limping corpse. Jesus.
New poster to this board, but long term follower.
Inclined to agree with FJ in so far as there is something irrational about the short term price action. It’s very frustrating and I’m scratching my head too. With that said, if the potential here is as good as most believe, then the irrational share price actually gives me confidence. Someone is going to end up with these assets, and in the end it’ll be for much more than 24-25p a share. Let the big boys squabble and the politics play out, but unless the Ecuadorean government step in and put up barriers (which doesn’t seem likely, although it’s hardly Australia in that respect), holders will profit from these prices, although by how much is beyond me right now.
Interims don’t exactly fill me with confidence, although with that they’re more likely to improve from here on out. I wonder what the likes of RG and Lombard see which makes them continue to hold/increase their positions? This really does need some decent news flow, and director purchases wouldn’t go amiss now that they’ll be out of their close period. Expecting a drop today, but I hope not.
Thanks for the replies. Nice to see the 250k trades (hoping they are indeed buys).
56 million 12p options expiring June 2022. Are these being flipped and dragging the price down with it?
4.1m buy followed by another 500k. Given some of the recent trades I’m expecting a holdings RNS.
What do you mean by a friendly transfer of shares between MMS? What does this accomplish and why would the price be so volatile as a result? Their job is to create liquidity and fulfil demand. Don’t overthink this - price increases as buying pressure increases, assuming no foul play. Even if it’s getting pumped, this is still accomplished with buying. The shares are fairly tightly held so it’s no surprise at all that sizeable holders are probably offloading into these rapid, fairly unsustainable rises.
One pound soon? Based on what? Fantastic due diligence. I must say you’ve convinced me!
Hard to call the big trade this morning... It’s not showing as a delayed print, but if it were I’d consider it a factor in yesterday’s rise. Given that we’ve dropped off since this open, I’d say someone savvy was selling into the rise, and now there’s a bit of a stalemate while the market waits for someone to make the next move. Positive news flow either way so it’s a hold for me.
Approvals in two territories and a positive business update and yet the price hasn’t risen much at all - There is clearly selling pressure from somewhere, and some of the trades today are evidence of this. What you take from that is a different matter, but admittedly it can be confusing when the story says one thing and the money/price says another. We’re probably seeing action similar to VRP, where it spiked and then consolidated while larger holders sorted themselves out. Look how that turned out today - nicely in the blue after days of looking like the fun was over. I’m happy to hold for now that’s for sure.
Any particular reason you capitalise your words?
With regard to him selling, who knows why? We’re all in this for profit so he was probably being smart and selling into the spike. It’s not like the entire position was closed. It does say in the RNS that it was “an acquisition or disposal of financial instruments”, rather than voting rights, so perhaps he wasn’t disposing of the standard class of shares that we are familiar with, but other, more complicated instruments.
News flow is positive and personally, his lower overall position doesn’t worry me. Be careful about reading too far into these kinds of news releases - investors (especially the pros) have all kinds of reasons for selling when to you or I often interpret it as “disaster must be imminent”.
Some profit taking perhaps, but a pretty brutal and inescapable market wide sell off is what’s impacting most stocks today, no matter what you’re invested in, courtesy of dire (albeit expected) GDP numbers and earnings reports. This has little to do with the company and more to do with general sentiment. Could be in for a bumpy ride in the next week or two. Help us all out JPow... get printing!